Hin Sang Group (International) Holding Co 6893.HK · HKD
Consumer Staples · HKEX · 🇭🇰 Hong Kong
0.36
+9.23%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Hin Sang Group (International) Holding Co
Its shares trade on HKEX under the ticker 6893.HK. It has been listed since 16 October 2014. In the fiscal year to 31 March 2026, it reported revenue of HK$104.6m and a net loss of HK$45.8m. At that date it held total assets of HK$531.0m and shareholders' equity of HK$113.1m.
Hin Sang Group (International) Holding Co. Ltd. engages in the marketing, sale, and manufacture of health care products. The company employs 253 full-time employees The company went IPO on 2014-10-16. The firm operates its business through three segments. The Product Development segment is engaged in the sales of products developed by the Company under own brands. The Brand Development and Management segment is engaged in the sales and distribution of products with exclusive distribution rights. The Trading of Goods segment is engaged in the sales and distribution of products purchased from authorized dealers, independent traders, manufacturers and parallel importers.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Personal Care Products
- Listed since
- 16 Oct 2014
- Employees
- 253
- Website
- hinsanggroup.com/en ↗
Leadership
Pay as last reported
- Mr. Siu Hin PangExecutive Chairman of the Board, Chief Executive Officer, FounderHK$2.7m
- Ms. Lai Man KwanFounder, Managing Director, Executive Director, since 2010HK$2.2m
- Mr. Wah Kit CheukAssistant Sales Director
- Mr. Wing Keung MakInformation Technology Manager
- Mr. Yeung Tak ChenCompany Secretary
- Ms. Shanshan TianNon-Executive Director
- Mr. Chi Kit LauNon-Executive Independent DirectorHK$180,000
- Mr. Luk Shiu LeeNon-Executive Independent DirectorHK$240,000
- Dr. Sing Hing TangNon-Executive Independent DirectorHK$180,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Hin Sang Group's Product Development segment sells own-branded health care products effectively.
- The Brand Development and Management segment handles exclusive distribution rights for health care products.
- Trading of Goods segment sources products from authorized dealers and parallel importers efficiently.
Weaknesses
- Hin Sang Group has only 253 employees, which may limit operational capacity.
- The company's IPO in 2014 may indicate limited recent capital growth.
- The Consumer Staples sector faces constant market saturation challenges.
Opportunities
- Expanding into new markets within the Consumer Staples sector could boost sales.
- Increasing demand for health care products presents growth potential.
- The Brand Development and Management segment can leverage exclusive rights for new products.
Threats
- Competition in the Consumer Staples sector is intense and growing.
- Health care product regulations may increase operational costs.
- Economic downturns could reduce consumer spending on non-essential health care items.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.